MSHO members are invited to partner with the Leukemia and Lymphoma Society for a day of advocacy in Lansing on May 17th.
Shortage of National Bleomycin Sulfate for Injection
PROCEED WITH CAUTIOUS OPTIMISM
The recent decision by the Centers for Medicare and Medicaid Services (CMS) to cover allogeneic hematopoietic cell transplantation (alloHCT) for eligible patients with sickle cell disease (SCD), myelofibrosis, and multiple myeloma (MM) is a boon for hematology.
Review ACCCs Medicare Part B Slide Deck Here
The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), passed earlier this year, repealed the fundamentally flawed Sustainable Growth Rate formula and introduced significant changes in how Medicare will pay oncologists for the care they provide in the coming years.